Sequent Scientific Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 1.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sequent Scientific Limited (associated with Viyash Scientific Limited) has filed its financial results with the exchange for the quarter and half-year ended September 30, 2025. This is a routine quarterly compliance disclosure under listing requirements. The headline does not include specific numbers such as revenue, profit, or margins. Investors should refer to the detailed results document for actual financial performance.
This is a standard regulatory filing with no immediate price-moving implication on its own. Shareholders should review the full results document for actual revenue, profit, and margin figures before drawing any conclusions.